DMP.DE
DMP.DE
DE000A2GS5D8
Dermapharm Holding SE I
Loading chart...

Company Profile

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Related stocks

PRGO
PRGO • Ireland
Perrigo Company plc
15.06 USD
2.09B USD 1Y -33%
PPGN.SW
PPGN.SW • Switzerland
POLYPEPTIDE N
43.85 CHF
1.74B USD 1Y +68.2%
SFZN.SW
SFZN.SW • Switzerland
SIEGFRIED N
67.5 CHF
3.56B USD 1Y -18.7%
FAGR.BR
FAGR.BR • Belgium
FAGRON
22.2 EUR
1.83B USD 1Y +10.1%
EVT.DE
EVT.DE • Germany
Evotec SE I
2.77 EUR
551.16M USD 1Y -59%
ALVO
ALVO • Luxembourg
Alvotech
5.78 USD
2.06B USD 1Y -34.7%
HIK.L
HIK.L • United Kingdom
HIKMA PHARMACEUTICALS PLC ORD S
1,612 GBp
4.41B USD 1Y -12.5%
ALM.MC
ALM.MC • Spain
ALMIRALL S.A.
10.08 EUR
2.46B USD 1Y -15.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
31.1% p.a.
Max Drawdown (5Y)
-66.6%
Sharpe Ratio (5Y)
-0.53
Beta Factor
0.87
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 219%.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (31.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -66.6% in the extended horizon.
ende